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Tithonia diversifolia (Asteraceae), is used as traditional medicine in tropical countries 
for the treatment of various diseases, including malaria. Although numerous studies 
have assessed the antimalarial properties, nothing is known about the effect of T. 
diversifolia extracts on trypanosomiasis. In this study extracts of T. diversifolia aerial 
parts were evaluated for their bioactivity against Trypanosoma brucei. The activity was 
studied against bloodstream forms of T. brucei (TC221), as well as against mammalian 
cells (BALB/3T3 mouse fibroblasts), as a counter-screen for toxicity. Both methanolic 
and aqueous extracts showed significant effects with IC50 values of 1.1 and 2.2 µg/mL 
against T. brucei (TC221) and 5.2 and 3.7 µg/mL against BALB/3T3 cells, respectively. 
A bioassay-guided fractionation on the methanolic extract yielded in identification of 
active fractions (F8 and F9) with IC50 values of 0.41 and 0.43 µg/mL, respectively, 
against T. brucei (TC221) and 1.4 and 1.5 µg/mL, respectively, against BALB/3T3 
cells,. The phytochemical composition of the extracts and the purified fractions were 
investigated using HPLC-ESI-MS/MS and 1D and 2D NMR spectra showing the 
presence of sesquiterpene lactones that in turn were subjected to the isolation procedure. 
Tagitinin A and C were rather active but the latter presented a very strong inhibition on 
T. brucei (TC221) with an IC50 value of 0.0042 µg/mL. This activity was 4.5 times 
better than that of the reference drug suramin. The results of this study shed light on the 
antitrypanosomal effects of T. diversifolia extracts and highlighted tagitinin C as one of 
the possible responsible for this effect. Further structure activity relationships studies on 
tagitinins are needed to consider this sesquiterpenes as lead compounds for the 
development of new antitrypanosomal drugs. 
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Abbreviations: 
1D and 2D NMR: One and two-dimensional nuclear magnetic resonance  
BALB//3T3 = Mouse fibroblasts 
CH2Cl2/MeOH: Methylene chloride/Methanol 
DMSO: Dimethylsulfoxide  
HAT: Human African Trypanosomiasis 
NTDs: Neglected tropical diseases  
SAR: Structure-activity relationship 
SI: Selectivity index 
STLs : Sesquiterpene lactones 
T. brucei: Trypanosoma brucei  
TC221: T. brucei bloodstream-form parasites 
TLC: Thin layer chromatography 
WHO: World Health Organization 
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Introduction 
 
Neglected tropical diseases (NTDs) are classified as a subgroup of infectious 
illnesses affecting more than a billion people worldwide and causing significant public 
health problems, particularly in marginalized populations of rural developing countries 
(Benelli and Mehlhorn, 2016). People suffering from NTDs live in close contact with 
infectious vectors and domestic livestock and represent an unattractive market to 
pharmaceutical industry investments. For this reason, in 2010 the World Health 
Organization (WHO) released its first report on the global treat posed by NTDs. In this 
report WHO prioritized 17 NTDs. Of these 17, the three major protozoan diseases, 
namely human African trypanosomiasis (HAT), Chagas disease and leishmaniasis, have 
been accounted as life-threatening infections (Mehlhorn 2015).  
African trypanosomiasis, which includes African sleeping sickness in humans 
(HAT) and “Nagana” in cattle, are fatal vector-borne diseases caused by the 
kinetoplastid protozoan pathogen Trypanosoma brucei (T. brucei). HAT is endemic in 
36 sub-Saharan African countries and is transmitted to the host by the bites of tsetse 
flies (Glossina spp., Glossinidae). The disease progresses through two stages, i.e. from a 
haemolymphatic first stage to a meningoencephalitic second stage, in which the 
parasites enter the central nervous system. HAT is caused by two subspecies of the 
parasite T. brucei: T. b. gambiense (West Africa) and T. b. rhodesiense (East Africa). T. 
b. rhodesiense as well as other African trypanosomes such as T. congolense, T. vivax 
and T. brucei brucei infect wild and domestic animals causing “Nagana”, which has a 
significant impact on socioeconomic development in many parts of rural Africa. In 
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about eleven million square kilometres of farming land infested by the tsetse flies, cattle 
represent an important zoonotic reservoir for human infections. 
There is a pressing need to develop novel and cost-effective drugs to treat HAT, 
especially at later stages when the parasites infect the brain. The lack of potential 
vaccine candidates together with the uncertainty for a successful chemotherapy against 
HAT add impetus to explore naturally occurring compounds as inspiring leads for 
designing future trypanocidal drugs (Scotti et al., 2016). 
Among several medicinal plants traditionally used in Africa to treat different 
diseases and having potential as a source of trypanocidal compounds, our attention has 
been attracted by Tithonia diversifolia (Hemsl.) A. Gray. This plant, belonging to the 
Asteraceae family, is also known as Mexican sunflower, being native to central 
America. It is distributed in tropical areas of South America, Asia and Africa where it 
can be considered as a weed of cultivated and non-cultivated lands (Chagas-Paula et al., 
2012; Ayeni et al., 1997). Given its abundance, T. diversifolia enjoys a long use as a 
traditional remedy in tropical regions (Heinrich, 2000). In particular, the plant leaves are 
used in Africa to treat malaria (Heinrich et al., 1998; Njoroge and Bussman, 2006). 
Noteworthy, this use was then confirmed by scientific studies (Goffin et al., 2002; 
Elufioye and Agbedahunsi, 2004; Oyewole et al., 2008) where the bioactive compounds 
were identified as germacranolide-type sesquiterpene lactones called tagitinins, with 
tagitinin C as the lead compound (Goffin et al., 2002; Ferreira et al., 2005). These 
sesquiterpene lactones (STLs) were also proven to exhibit anti-inflammatory/analgesic 
(Owoyele et al., 2004), antiproliferative (Liao et al., 2011), antifeedant (Ambrósio et al., 
2008) and insecticidal activities (Castaño-Quintana et al., 2013). Other secondary 
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metabolites characteristics of T. diversifolia are diterpenoids, flavonoids, chlorogenic 
acid derivatives and essential oils (Orsomando et al., 2016). 
Given the potential of T. diversifolia secondary metabolites to interact with 
protozoan parasites (Goffin et al., 2002), here we have investigated the effect of a T. 
diversifolia methanolic leaf extract against T. brucei using a bioassay-guided 
fractionation approach, leading to the identification of tagitinin A and C as main active 
constituents. To our knowledge, nothing is known about either the anti-trypanosomal 
activity of T. diversifolia extracts or the components responsible for this effect. 
Different techniques were applied for the identification of phytoconstituents. 
Methanolic extract was initially studied by 1H NMR and 2D NMR to obtain information 
about the main compounds. The total extract was subsequently fractionated by flash 
chromatography in 19 fractions of increasing polarity which were tested against T. 
brucei in vitro. A few fractions showed antitrypanosomal activity. Active fractions were 
analysed by HPLC MS-MS and by NMR to find the phytoconstituents responsible for 
activity towards the protozoan parasite. The two most abundant sesquiterpene lactones 
in the active fractions were finally purified and assessed for their antitrypanosomial 
activity. 
 
Material and Methods 
 
Chemicals and reagents 
 
LC–MS grade acetonitrile (ACN) and methanol (MeOH) were obtained from J. 
T. Baker (Phillipsburg, USA). HPLC-grade formic acid was purchased from Dikma 
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Tech. Inc. (Beijing, China). Cycloexane was obtained from Scharlau. Deuterated 
chloroform was purchased from Sigma-Aldrich. Water (H2O) was purified by a Milli-Q 
system (Millipore, Billerica, MA, USA) in our laboratory. Other reagents were of 
analytical grade. 
 
Plant material 
 
Leaves of T. diversifolia (Asteraceae) were collected in the city of Dschang, 
western region of Cameroon (N 05°26’18”, E 10°04’07”, 1450 m a.s.l) by Saague T. 
Maximiliene and Prosper C. Biapa Nya in January 2016 during the dry season. 
Botanical authentication was performed by plant taxonomist Mr. Nana of the National 
Herbarium, Yaoundé, Cameroon, where a voucher specimen coded 10196/HNC was 
deposited.  
 
Preparation of plant extracts 
 
T. diversifolia leaves were air-dried in the shade at room temperature (≈25°C) 
for 3 days and conserved in wrapping papers before extraction. Fifty g of dry leaves 
were reduced into powder using a blender MFC DCFH 48 IKA-WERK (D-Staufen) 
equipped with sieves of 2-mm size in diameter. The powder was subsequently 
macerated in 500 ml of methanol (MeOH) for 24 h and filtered. The filtrate was 
concentrated under reduced pressure at 30°C with a rotary evaporator and freeze-dried 
to obtain a crude MeOH extract (2.64 g, 5.3% yield, Tith-MeOH). Using the same 
protocol, an aqueous extract was obtained by maceration of 5 g of leaves in 50 mL of 
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deionized water to get 0.42 g (8.4%, Tith-H2O) of extract. The extracts were kept in 
glass vials protected from light at -20°C before chemical analysis and anti-trypanosomal 
experiments. 
 
Apparatus and chromatographic conditions 
 
Detection and quantification of the compounds were performed on an LC–MS 
system. The LC–MS equipment (Varian Inc.) contained a chromatographic system 
(Varian LC-212) coupled with a Varian 500-MS (ion trap) mass spectrometer fitted 
with an ESI source (Varian). MS conditions were the following: needle potential −5.0 
kV, shield 600 V, spray chamber temperature 50°C, drying gas pressure 10 psi, drying 
gas temperature 350°C, capillary voltage 80 V, RF loading 100, and MS range 150–
2000 Da. MSn spectra were obtained during the chromatography run by using the turbo-
dds (tdds) utility of the instrument. HPLC-DAD analysis was carried out by an Agilent 
1100 series liquid chromatograph equipped with an Agilent 1100 Diode Array (DAD). 
An Eclipse XDB-C8, 5 µm, 4.6 x 150 mm column (Agilent Technologies) was used. 
The mobile phase consisted of (A) aqueous formic acid (0.1 %) and (B) acetonitrile. 
Gradient conditions were: 0–30 min, linear gradient from 10 % to 100 % of B; 30–35 
min, isocratic conditions at 100 % of B; 35–36 min, linear gradient from 100% to 10% 
of B; 36-40 min, isocratic conditions at 10% of B. Flow rate: 1 mL/min. Calibration 
curves were obtained by standard solutions of rutin for flavonoid derivatives (UV 
detection at 350 nm), chlorogenic acid for caffeoylquinic derivatives (UV detection at 
330 nm) and gallic acid for small phenols (UV detection at 280 nm). The concentration 
ranges were 11.7–117, 13.2–132, and 14.6-146 µg/mL for chlorogenic acid, rutin and 
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gallic acid, respectively. The limits of detection (LOD) and quantification (LOQ) were 
1.5 and 4.0 g/ml and 0.5 and 1.5 g/ml for chlorogenic acid and rutin, respectively. 
 
Fractionation of the extract, isolation of Tagitinin A and C 
 
The crude methanolic extract of T. diversifolia leaves (1 g) was dissolved in 
methanol and adsorbed on silica gel (40 mesh, 2 g). Subsequently, the solvent was 
removed under vacuum to obtain a dried powder. This powder was packed in a pre-
column, which was fixed on a Silica column (Buchi Sepacore® silica 12 g). Separation 
was performed on a Varian Intelliflash Flash chromatograph. The eluent was initially 
cyclohexane followed by an increasing percentage of methanol up to 30 % in 120 min. 
The flow rate was 1 mL/min and the chromatogram was monitored at 220 and 340 nm. 
Eluted fractions were checked by TLC and collected in 19 groups. The solvent was 
removed under vacuum and the weight of each fraction obtained was as follows: 1 (25.8 
mg), 2 (15.0 mg), 3 (17.1 mg), 4 (18.5 mg), 5 (23.1 mg), 6 (26.7 mg), 7 (13.9 mg), 8 
(16.7 mg), 9 (19.4 mg), 10 (18.0 mg), 11 (8.9 mg), 12 (5.3 mg), 13 (7.0 mg), 14 (4 mg), 
15 (104.6 mg), 16 (128.4 mg) 17 (78.7 mg), 18 (59.7 mg), 19 (38.2 mg). 
For tagitinin isolation 250 g of dried plant material was extracted using 
dichloromethane (550 mL x 3 times) using ultrasound bath. Liquids were collected, 
filtered and pooled and solvent was evaporated under vacuum. The crude extract (9.5 g) 
was used for chromatographic separation. A silica gel column (10 x 100 cm) was 
packed using hexane as solvent. Extract was charged in the column and hexane was 
used for elution, then hexane/ethyl acetate with an increasing ratio, starting from 6/1 to 
1/1, was used as eluent system. Fifty-five fractions were pooled on the basis of their 
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chromatographic behaviour. Further separations were achieved on Sephadex LH20 
column (5 x 40 cm) eluting with dichloromethane. Tagitinin A and tagitinin C were 
isolated as pale oil (600 and 250 mg, respectively). Their spectral data were compared 
with those of literature (Baruah et al., 1979). 
NMR analysis was obtained on a Bruker AVANCE III spectrometer operating at 
400.13 MHz for 1H-NMR. 2D spectra, HSQC-DEPT, HMBC, COSY and TOCSY were 
used for identification of compounds occurring in mixtures. Samples were dissolved in 
deuterated chloroform and used for analysis. For quantitative purposes, previously 
published conditions were used (Comai et al., 2010). 
 
 
T. brucei and mammalian cell culture   
The cell culture conditions and the growth inhibition assay on T. brucei and 
Balb/3T3 cells were performed as described before (Petrelli et al., 2016). T. brucei 
bloodstream forms (TC221) were cultured at 37 °C with 5 % CO2 in HMI-9 medium 
supplemented with 10 % (v/v) heat-inactivated fetal bovine serum (Gibco). Mouse 
BALB/3T3 fibroblast (ATCC no CCL-163) were cultivated at 37 °C and 5 % CO2 in 
Dulbecco’s modified Eagle’s medium (Sigma), supplemented with 10 % (v/v) heat-
inactivated fetal bovine serum, glutamine (0.584 g/L) and 10 mL/L of 100 × penicillin-
streptomycin (Gibco BRL) (Hirumi and Hirumi, 1989). 
 
Growth inhibition assay on T. brucei and BALB/3T3 cells   
The methanolic extract and its fractions were dissolved in dimethyl sulfoxide 
(DMSO). They were serially diluted with growth medium to concentrations ranging 
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from 2 × 10-5 to 200 µg/mL in 96-wells microtiter plates (100 µL/well). Subsequently, 
100 µL of T. brucei or mammalian cell culture was added to each well (20,000 
cells/well). After 48 h incubation, the plates were treated for 24 h with 20 µL of 0.5 mM 
resazurine (Sigma-Aldrich). They were subsequently quantified by fluorescence (540 
nm excitation and 590 nm emission) using an Infinite M200 microplate reader (Tecan 
Group, Ltd.). The IC50 values were calculated by fitting the data to a log inhibitor vs. 
response curve (variable slope, four parameters) using the GraphPad Prism 5.04 
software. 
 
Results and Discussion 
 
Characterization of T. diversifolia extracts by NMR and HPLC-MSn  
 
In order to establish the phytochemical composition of the Tith-MeOH extract, 
we decided to use a multi-technique approach. As a first step the Tith-MeOH extract 
was dissolved in deuterated chloroform (final concentration 20 mg/mL) and different 
spectra were acquired namely 1H-NMR, HSQC-DEPT, HMBC and COSY experiments. 
Diagnostic signals of sesquiterpene sp2 protons were detected, and assigned on the basis 
of the 1H, HSQC, HMBC and COSY data as compared with the literature (Baruah et al., 
1979). These results are reported in Table 1. A representative portion of a HSQC-DEPT 
spectrum is shown in Figure 1 indicating the assigned positions.  
Many other signals were detected and may be linked to other phytoconstituents. 
For this reason, HPLC-MSn analysis was performed in order to identify other secondary 
metabolites occurring in the crude extract. The fragmentation pathways for the main 
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sesquiterpenes of T. diversifolia were also studied and are reported in Figure 2. Six 
different sesquiterpenes were detected and their structures were determined on the basis 
of HPLC-MSn analysis. Limited information is available related to ESI/MS behaviour 
of these sesquiterpenes. Abea et al. (2015) reported proposed fragmentation pathways of 
tagitinin F. In our analysis, we observed that the tirotundin derivatives (compounds 4 
and 5, Figure 3) are characterized in MS2 by three main fragments ascribable to the loss 
of an ester side chain, a water molecule and an ether bridge or lactone ring with 
rearrangement at m/z 265, 247 and 229, respectively (Figure 2). The same fragments are 
detectable in the MS2 spectra of compound 6 at m/z 279, 261 and 243 (Figure 2) 
presenting additional 14 Da due to the presence of a methyl group. Polyphenol 
derivatives, mainly caffeic acid derivatives and flavonoids, were also identified. Table 2 
reports the different constituents identified. Phytochemical analysis showed that the T. 
diversifolia extract is complex and contains sesquiterpenes, phenylpropanoids and 
flavonoid derivatives as main constituents. 
 
In vitro evaluation of antiprotozoal activity of bioactive fractions, tagitinin A and 
tagitinin C 
Two extracts (Tith-MeOH and Tith-H2O) were prepared from the aerial parts of 
T. diversifolia to assess their in vitro antitrypanosomal activity (Table 3). The 
methanolic extract was two times more active against T. brucei than the aqueous extract 
(IC50 = 1.08 and 2.18g/mL, respectively) and was therefore chosen for further 
fractionation. The methanolic extract was subjected to chromatographic separations on 
silica gel and the fractions with increasing polarity collected after each purification step 
(F1-F19) were tested against the TC221 cells with the purpose of following the 
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antitrypanosomal activity. The bioassay-guided purification of the Tith-MeOH extract 
gave two fractions (F8 and F9, Table 3) showing significantly higher antitrypanosomal 
effects in our cell-based assay (IC50 = 0.41 and 0.43g/mL, respectively). Bioassays 
performed on the fractions from Silica-based chromatography of Tith-MeOH extracts 
showed the effect on T. brucei vs. mammalian cell proliferation (Table 3). 
1H-NMR of the 16 assayed fractions (Figure 4) clearly shows the presence of 
signals ascribable to sesquiterpene derivatives as well as other aromatic compounds in 
the most active mixtures, namely F7 to F11. In all the fractions, the signals ascribable to 
phenolic and phenylpropanoid derivatives were not detectable or poorly detectable. We 
decided to consider the most active fractions, thus the ones showing IC50 <1.6 µg/mL, 
i.e. fractions 8-11, which were analysed for the contents of tagitinins A and C. Due to 
the non-commercially availability of tagitinins as reference compounds, the 
quantification of the main derivatives, namely tagitinins A and C, was performed using 
an 1H-NMR approach using caffeine as internal standard (Comai et al., 2010) and the 
amounts of these STLs in the active fractions were reported in Table 4. Results showed 
that bioactivity of the obtained fractions can be in part ascribed to STLs constituents. 
Isolated tagitinin A and C were also tested. As reported in Table 5, tagitinin C resulted 
by far the most active compound compared with active fractions. Notably, tagitinin C 
was 4.5 times more active than the reference compound suramin. Furthermore, selective 
index for tagitinine C was 3 showing preferential effect on target cells compared with 
tagitinin A (1.3). The large difference in bioactivity observed for the tagitinin C and A 
indicates the need for the evaluation of other tagitinine derivatives in order to explore 
possible structure activity relationships.  
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Potent and selective antitrypanosomal activity of different plant sequiterpenes 
such as α-eudesmol, hinesol, nardosinone and 4-peroxy-1,2,4,5-tetrahydro-α-santonin 
(Otoguro et al. 2011) has been previously reported, as well as the possible usefulness of 
sesquiterpenes as lead compounds for the development of new antitrypanosomal drugs 
(Saeidnia et al. 2013). 
 
As regards the mode of action of T. diversifolia STLs on trypanosome cell, some 
considerations can be made. As reported by Schimdt et al. (1999), STLs possessing an 
,-unsaturated moiety in the form of -methylene--lactone can act as a Michael 
acceptor, reacting with nucleophiles such as free thiol groups (R-SH) in proteins leading 
to macromolecular dysfunction, oxidative stress and genetic mutations as a result of the 
oxidative stress. The presence of one potentially reactive α,β-unsaturated carbonyl 
group as a pharmacophore is often associated with significant antiprotozoal and 
cytotoxic activities. Tagitinin A has α,β-unsaturated carbonyl group in the -lactone 
ring, whereas tagitinin C has a carbonyl group conjugated with two double bonds in the 
germacrene ring and an α,β-unsaturated carbonyl group in the -lactone ring. The 
measured activity of the two compounds showed the importance of the carbonyl group 
conjugated with two double bonds because of the greater antitripanosomal activity of 
tagitinin C. The mechanism of these compounds against trypanosomes may be related to 
the capability to form thiol adducts with components found in the cellular environment 
such as trypanothione, glutathione and SH-groups in proteins. The lack of reduced 
trypanothione and other SH-group containing substances may in turn lead to that the 
parasite cells become more vulnerable to oxidative stress (Wink, 2008). The same 
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mechanism of action may occur in the mammalian fibroblasts (BALB/ 3T3), where 
glutathione depletion renders the cells prone to oxidative stress. 
 
Conclusions 
Overall our results, although preliminary, confirmed the usefulness of T. 
diversifolia as an effective herbal remedy in the African traditional medicine and 
highlighted the opportunity to use the tagitinins as inspiring leads for designing future 
trypanocidal drugs. Further studies are needed in particular to increase the knowledge 
about the mode of action and the possible molecular targets related to the 
antitrypanosomal activity of tagitinins. The opportunity to study different derivatives as 
well as strictly related sesquiterpene can be a good opportunity to explore structure 
activity relationships. Also synthetic or semisyntetic derivatives can be produced in 
order to follow a rational approach for the development of more active compounds. 
Finally further investigation will be needed in order to assess the real efficacy vs. 
toxicity through in vivo assays. 
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Table 1. Diagnostic assignments of tagitinins A and C from NMR spectra of Tith-
MeOH extract. Assignments were obtained comparing HSQC-DEPT, HMBC and 
COSY data with the literature (Baruah et al., 1979).  
          Tagitinin C           Tagitinin A 
Position H C Position H C 
1 6.93 d 
J=13.5 
159.6 1 4.23 78.4 
2 6.21  129.5 6 4.55 81.8 
13 6.36-5.81 124.0 8 5.59 69.9 
5 5.88 137.6 13 6.25-5.53 121.7 
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Table 2. HPLC-MS constituents identified in T. diversifolia methanolic extracts. 
Ret. 
time 
Compound Polarity 
[M-H]- or 
[M+H]+ 
Fragments 
2.53 Quinic acida Negative 191 85 
12.0 Chlorogenic acida Negative 353 191-179 
13.9 Rutina Negative 609 
301-271-255-
179-151 
14.5 Quercetin-glucuronide Negative 477 301-179-151 
14.6 1,5-Dicaffeoyl quinic acida Negative 515 
353-191-173-
127 
14.8 3,4-Dicaffeoyl quinic acid Negative 515 
353-191-179-
173 
15.7 3,5-Dicaffeoyl quinic acida Negative 515 
353-191-173-
127-111-85 
18.8 Isorhamnetin Negative 315 300-272-228 
19.5 Tagitinin A Negative 367 279-261-235 
  Positive 369 281-263-245 
19.7 Tirotundin 3-O-methylether Positive 367 
279-261-243-
233-215 
  Negative 365 
277-233-215-
191-176 
20.8 Hispidulin Negative 299 
284-256-227-
212 
24.6 Tagitinin C Positive 349 261-243-215-
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173 
27.4 1-β-Methoxydiversifolin Positive 395 
293-275-261-
199-181 
26.8 
8-β-O-(2-methylbutyroyl)-
Tirotundin or 8-β-O-
(isovaleroyl)-Tirotundin 
Positive 367 265-247-229 
       aconfirmed by the injection of a reference compound 
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Table 3. Activity of  T. diversifolia leaves extracts and fractions 1-19 against T. brucei TC221 and 
BALB/3T3. 
Samples 
IC50 (g/mL) Selectivity 
Index (SI) T. brucei (TC221) BALB/3T3 
Crude methanol extract (Tith-MeOH)  1.05 ± 0.18 5.15 ± 0.82 4.9 
Crude aqueous extract (Tith-H2O) 2.18 ± 0.06 6.71 ± 0.48 3 
Fractions from methanol extract (Tith-MeOH)   
Fraction 1  62.05 ± 20.4 - - 
Fraction 2   13.69 ± 1.8 52.16 ± 3.1 3.8 
Fraction 3 8.29 ± 0.79 17.52 ± 2.9 2.1 
Fraction 4  8.28 ± 0.56 12.85 ± 1.1 1.5 
Fraction 5   4.37 ± 1.98 7.65 ± 0.85 1.7 
Fraction 6 1.66 ± 0.66 4.37 ± 0.61 2.6 
Fraction 7  1.67 ± 0.51 2.78 ± 0.03 1.6 
Fraction 8  0.41 ± 0.22 1.44 ± 0.04 3.3 
Fraction 9 0.43 ± 0.09 1.47 ± 0.04 3.4 
Fraction 10 1.09 ± 0.37 2.36 ± 0.17 2.1 
Fraction 11  1.20 ± 0.21 2.66 ± 0.18 2.2 
Fraction 12 2.34 ± 0.55 4.24 ± 0.49 1.8 
Fraction 13 3.16 ± 0.89 6.03 ± 1.86 1.9 
Fraction 14  2.02 ± 0.88 5.10 ± 0.64 2.5 
Fraction 15 1.63 ± 0.61 3.17 ± 0.14 1.9 
Fraction 16 7.65 ± 1.61 19.34 ±  2.76 2.5 
Fraction 17  >100 - - 
Fraction 18 >100 - - 
Fraction 19 >100 - - 
Pure compounds g/mL(M) g/mL(M)  
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*n.d. not determined 
  
Tagitinin A 0.356 ± 0.17 (0.97) 
0.467 ± 0.21 
(1.27) 
1.3 
Tagitinin C 
0.0042 ± 0.0005 
(0.0121)  
0.012 ± 0.001 
(0.036)  
3 
Reference drug g/mL(M) g/mL(M)  
Suramin 
0.0191 ± 0.002 
(0.0147)  
n.d.* n.d.* 
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Table 4.  Amount of tagitinins in the bioactivity-guided selected fractions. The amount is 
shown as the percentage of the total volume, IC50 are expressed in µg/mL.   
Samples 
Tagitinin  
A % 
Tagitinin  
C % 
T. brucei (TC221) 
IC50 (µg/mL) 
Crude methanol extract (Tith-
MeOH)  
0.83 ± 0.01 1.10 ± 0.01 1.05 ± 0.18 
Active fractions from methanol extract (Tith-MeOH) 
Fraction 8  10.8 ± 0.01 9.39 ± 0.01 0.41 ± 0.22 
Fraction 9 8.36 ± 0.01 8.18 ± 0.01 0.43 ± 0.09 
Fraction 10 7.03 ± 0.01 7.09 ± 0.01 1.09 ± 0.37 
Fraction 11  7.07 ± 0.01 6.51± 0.01 1.20 ± 0.21 
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Figure 1. HSQC-DEPT (MeOD) of a T. diversifolia extract. TA and TC indicate signals 
of Tagitinin A and Tagitinin C, respectively. 
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Figure 2. Mass spectra of the main sesquiterpenoids of Tithonia diversifolia and 
proposed fragmentation pathways. 
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Figure 3. Structures of main sesquiterpenes identified in T.diversifolia extracts. 
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Figure 4. 1H-NMR of T. diversifolia fractions 1-16, diagnostic signals indicating 
the presence of sesquiterpene and phenolics are highlighted with coloured rectangles. 
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